Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Change in Receivables (2016 - 2024)

HealthLynked (HLYK) has disclosed Change in Receivables for 9 consecutive years, with -$25557.0 as the latest value for Q4 2024.

  • On a quarterly basis, Change in Receivables fell 23.68% to -$25557.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$20861.0, a 27.86% increase, with the full-year FY2024 number at -$20861.0, up 27.86% from a year prior.
  • Change in Receivables was -$25557.0 for Q4 2024 at HealthLynked, down from -$13002.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $38152.0 in Q1 2021 to a low of -$106592.0 in Q4 2020.
  • A 5-year average of -$7897.5 and a median of -$7678.5 in 2020 define the central range for Change in Receivables.
  • Biggest YoY gain for Change in Receivables was 1673.37% in 2024; the steepest drop was 559.11% in 2024.
  • HealthLynked's Change in Receivables stood at -$106592.0 in 2020, then skyrocketed by 89.49% to -$11199.0 in 2021, then surged by 175.26% to $8428.0 in 2022, then crashed by 345.18% to -$20664.0 in 2023, then decreased by 23.68% to -$25557.0 in 2024.
  • Per Business Quant, the three most recent readings for HLYK's Change in Receivables are -$25557.0 (Q4 2024), -$13002.0 (Q3 2024), and $4938.0 (Q2 2024).